Crowley John J 4
4 · Centessa Pharmaceuticals plc · Filed Feb 4, 2025
Insider Transaction Report
Form 4
Crowley John J
Chief Financial Officer
Transactions
- Award
Share Option (right to buy)
2025-02-03+250,000→ 250,000 totalExercise: $16.90Exp: 2035-02-03→ Ordinary Shares (250,000 underlying)
Footnotes (2)
- [F1]1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 3, 2025.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.